Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Cardiovascular Function and Risk Factors, and Lipoproteins and Cardiovascular Health.
Colchicine for secondary prevention of vascular events: a meta-analysis of trials
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis
Colchicine in Acute Myocardial Infarction
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
The effects of colchicine on lipoprotein(a)- and oxidized phospholipid-associated cardiovascular disease risk
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction
Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome
Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis
Colchicine in Patients with Chronic Coronary Disease
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial